Stock Analysis on Net
Stock Analysis on Net
Stock Analysis on Net without ads!

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Vertex Pharmaceuticals Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Accounts payable 1.57 1.85 1.80 1.69 1.84 1.94 1.83 1.78 1.63 1.47 1.61 1.73 1.78 1.70 1.67 0.76 1.27 1.22 1.45 1.01 1.04 1.06
Accrued expenses 11.59 11.27 11.59 14.53 13.61 12.90 12.38 14.48 14.60 11.69 11.68 13.38 12.77 12.26 11.72 13.55 13.60 12.07 12.50 12.56 12.13 12.65
Other current liabilities 1.20 1.54 1.67 1.78 1.77 1.69 1.61 1.61 1.39 2.71 2.32 1.46 1.92 1.99 1.72 1.30 1.53 2.01 2.00 1.60 1.85 2.35
Current liabilities 14.36% 14.65% 15.06% 18.00% 17.22% 16.53% 15.82% 17.86% 17.62% 15.87% 15.61% 16.57% 16.47% 15.95% 15.11% 15.62% 16.40% 15.29% 15.95% 15.17% 15.03% 16.05%
Long-term operating lease liabilities 7.21 7.50 7.20 7.38 6.35 6.72 6.85 7.14 2.91 1.50 1.53 1.63 1.79 1.96 2.09 2.29 2.34 2.64 2.81 2.88 3.02 3.04
Other long-term liabilities 4.59 4.74 4.95 4.96 4.97 4.65 4.50 4.71 6.08 5.08 5.52 5.80 5.72 6.03 6.15 4.10 4.67 5.55 6.05 6.42 6.71 6.79
Long-term liabilities 11.81% 12.24% 12.15% 12.34% 11.33% 11.37% 11.36% 11.85% 8.99% 6.58% 7.05% 7.43% 7.50% 7.99% 8.24% 6.39% 7.01% 8.20% 8.86% 9.30% 9.73% 9.83%
Total liabilities 26.17% 26.89% 27.21% 30.34% 28.55% 27.90% 27.18% 29.72% 26.61% 22.46% 22.66% 24.00% 23.98% 23.94% 23.35% 22.01% 23.42% 23.49% 24.81% 24.47% 24.75% 25.88%
Preferred stock, $0.01 par value; none issued 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, $0.01 par value 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02
Additional paid-in capital 16.43 17.91 19.96 20.16 24.91 26.98 29.61 31.05 35.27 30.46 32.77 33.78 36.21 38.05 40.69 43.25 45.56 48.61 51.23 56.15 62.51 61.90
Accumulated other comprehensive income (loss) 0.18 0.09 -0.06 -0.26 -0.42 0.30 0.57 0.13 0.11 0.07 -0.06 -0.01 -0.20 -0.07 0.00 0.58 0.37 0.08 0.12 0.09 -0.21 -0.27
Retained earnings 57.22 55.09 52.88 49.75 46.95 44.81 42.63 39.09 37.99 47.00 44.62 42.22 39.99 38.07 35.94 34.14 30.63 27.80 23.83 19.26 12.92 12.48
Shareholders’ equity 73.83% 73.11% 72.79% 69.66% 71.45% 72.10% 72.82% 70.28% 73.39% 77.54% 77.34% 76.00% 76.02% 76.06% 76.65% 77.99% 76.58% 76.51% 75.19% 75.53% 75.25% 74.12%
Total liabilities and shareholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).

The capital structure of the organization is characterized by a high reliance on equity financing, with shareholders' equity consistently representing between 69% and 78% of total liabilities and shareholders' equity. Total liabilities remained relatively stable for a significant period, generally fluctuating between 22% and 30% of the total balance sheet, indicating a conservative leverage profile.

Equity Composition and Organic Growth
A significant structural shift is observed within the equity components. Additional paid-in capital exhibited a steady and pronounced decline, falling from 61.90% in March 2021 to 16.43% by June 2026. Conversely, retained earnings demonstrated a strong upward trajectory, increasing from 12.48% in March 2021 to 57.22% by June 2026. This trend indicates that the company's equity base is transitioning from contributed capital to earned capital, reflecting sustained profitability and the accumulation of retained earnings over time.
Current Liability Trends
Current liabilities have remained relatively stable as a percentage of the total balance sheet, typically ranging between 14% and 18%. Accrued expenses constitute the primary component of these obligations, consistently accounting for 11% to 14% of the total liabilities and shareholders' equity. Accounts payable and other current liabilities represent minor portions of the total capital structure, showing minimal volatility.
Long-term Obligations and Lease Commitments
A notable change in long-term liability composition occurred starting in June 2024. Long-term operating lease liabilities, which previously trended downward from 3.04% in March 2021 to 1.50% in March 2024, experienced a sharp increase to 2.91% in June 2024 and continued to rise, peaking at 7.50% by March 2026. This represents a significant increase in the proportional weight of lease obligations within the total balance sheet.
Overall Liability Profile
Total liabilities saw a gradual increase in proportional weight toward the latter part of the observed period, rising from a low of 22.01% in September 2022 to a peak of 30.34% in September 2025, before settling slightly at 26.17% by June 2026. This increase is primarily attributed to the rise in long-term operating lease liabilities rather than an increase in short-term operational debt.

AI Ask an analyst for more